Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women
Marleen Nahuis1,2,3, Fulco van der Veen1, Jur Oosterhuis2, Ben Willem Mol1, Peter Hompes3, Madelon van Wely11Center for Reproductive Medicine, Department of Obstetrics and Gynaecology (H4-205), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 2Department of Obstetrics an...
Saved in:
Main Authors: | Marleen Nahuis (Author), Fulco van der Veen (Author), Jur Oosterhuis (Author), et al (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?
by: Gleicher Norbert, et al.
Published: (2011) -
Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis
by: Grassi Giuseppina, et al.
Published: (2006) -
The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections - a pharmacokinetic study
by: Kuo Hsin-Chih, et al.
Published: (2009) -
The importance of infertility duration and follicle size according to pregnancy success in women undergoing ovulation induction with gonadotropins and intrauterine insemination
by: Meryem Kuru Pekcan, et al.
Published: (2023) -
The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles
by: Chunxia Yang, et al.
Published: (2022)